Fulcrum Therapeutics (FULC) Shares Issued (2018 - 2026)
Fulcrum Therapeutics (FULC) posted quarterly Shares Issued of $11.6 million for Q2 2026, down 3.72% year-over-year from $12.1 million in Q2 2025, and down 16.49% quarter-over-quarter from $13.9 million in Q1 2026.
Fulcrum Therapeutics (FULC) Shares Issued (2018 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has reported Shares Issued for 9 consecutive years, with $11.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Issued fell 3.72% year-over-year to $11.6 million; the TTM figure through Jun 2026 stood at $11.6 million (down 3.72% YoY), while the FY2025 annual figure was $11.6 million, up 24.49% from the prior year.
- Shares Issued slipped to $11.6 million in Q2 2026 per FULC's latest filing, from $13.9 million in the prior quarter.
- Across five years, Shares Issued topped out at $13.9 million in Q1 2026 and bottomed at $5.9 million in Q3 2022.
- Historically, Shares Issued has averaged $10.0 million across 5 years, with a median of $10.4 million in 2023.
- On a YoY basis, Shares Issued climbed as much as 78.71% in 2024 and fell as far as 6.19% in 2024.
- Fulcrum Therapeutics' Shares Issued stood at $6.5 million in 2022, then surged by 53.32% to $10.0 million in 2023, then slipped by 6.19% to $9.4 million in 2024, then advanced by 24.49% to $11.6 million in 2025, then retreated by 0.11% to $11.6 million in 2026.
- Business Quant data shows FULC's Shares Issued at $11.6 million in Q2 2026, $13.9 million in Q1 2026, and $11.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Fulcrum Therapeutics | 285.31 Mn | 285.31 Mn | - | 11.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.63 Mn |
| Jun 30, 2026 | 11.63 Mn |
| Mar 31, 2026 | 13.93 Mn |
| Mar 31, 2026 | 13.93 Mn |
| Dec 31, 2025 | 11.65 Mn |
| Dec 31, 2025 | 11.65 Mn |
| Sep 30, 2025 | 11.87 Mn |
| Sep 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 12.08 Mn |
| Jun 30, 2025 | 12.08 Mn |
| Mar 31, 2025 | 12.01 Mn |
| Mar 31, 2025 | 12.01 Mn |
| Dec 31, 2024 | 9.35 Mn |
| Dec 31, 2024 | 9.35 Mn |
| Sep 30, 2024 | 4.59 Mn |
| Sep 30, 2024 | 4.59 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Mar 31, 2024 | 3.37 Mn |